Cargando…
Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial
IMPORTANCE: Severe early onset fetal growth restriction caused by placental dysfunction leads to high rates of perinatal mortality and neonatal morbidity. The phosphodiesterase 5 inhibitor, sildenafil, inhibits cyclic guanosine monophosphate hydrolysis, thereby activating the effects of nitric oxide...
Autores principales: | Pels, Anouk, Derks, Jan, Elvan-Taspinar, Ayten, van Drongelen, Joris, de Boer, Marjon, Duvekot, Hans, van Laar, Judith, van Eyck, Jim, Al-Nasiry, Salwan, Sueters, Marieke, Post, Marinka, Onland, Wes, van Wassenaer-Leemhuis, Aleid, Naaktgeboren, Christiana, Jakobsen, Janus C., Gluud, Christian, Duijnhoven, Ruben G., Lely, Titia, Gordijn, Sanne, Ganzevoort, Wessel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301225/ https://www.ncbi.nlm.nih.gov/pubmed/32585017 http://dx.doi.org/10.1001/jamanetworkopen.2020.5323 |
Ejemplares similares
-
Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction
por: Pels, Anouk, et al.
Publicado: (2019) -
Early‐onset fetal growth restriction: A systematic review on mortality and morbidity
por: Pels, Anouk, et al.
Publicado: (2019) -
Prenatal Use of Sildenafil in Fetal Growth Restriction and Its Effect on Neonatal Tissue Oxygenation—A Retrospective Analysis of Hemodynamic Data From Participants of the Dutch STRIDER Trial
por: Terstappen, Fieke, et al.
Publicado: (2020) -
STRIDER: Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis
por: Ganzevoort, Wessel, et al.
Publicado: (2014) -
Temporizing management vs immediate delivery in early‐onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open‐label randomized controlled trial
por: Duvekot, Johannes J., et al.
Publicado: (2020)